P-Hydroxylation of Phenobarbital: Relationship to (s)-Mephenytoin Hydroxylation (CYP2C19) Polymorphism-Reference-Cited by-同舟云学术

P-Hydroxylation of Phenobarbital: Relationship to (s)-Mephenytoin Hydroxylation (CYP2C19) Polymorphism

Published:2001-04 Issue:2 Volume:23 Page:115-118
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:Therapeutic Drug Monitoring

Author:

Hadama Atsuko,Ieiri Ichiro,Morita Toshihiro,Kimura Miyuki,Urae Akinori,Irie Shin,Kaneda Tatsuya,Mamiya Kohsuke,Tashiro Nobutada,Higuchi Shun,Otsubo Kenji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Effects of felbamate on the pharmacokinetics of phenobarbital

2. Pharmacokinetic Interactions Between Antiepileptic Drugs

3. A Mechanistic Approach to Antiepileptic Drug Interactions

4. CYP2C19 polymorphism effect on phenobarbitone

5. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs Used in Withdrawal Management and Post-Withdrawal Management;Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy;2023

2. Effect of S‐1 on blood levels of phenobarbital and phenytoin: A case report;Clinical Case Reports;2021-02-04

3. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics;Expert Opinion on Drug Metabolism & Toxicology;2020-10-29

4. Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus;Clinical Pharmacokinetics;2016-11-10

5. Farmacogenetica dei farmaci antiepilettici;EMC - Neurologia;2014-11